https://suwanews.sinethhospitals.com/news/infectious-diseases/bepirovirsen-chronic-hepatitis-b-functional-cure-phase-3 Suwa News en 2026-10-03T10:58:08+00:00 Investigational Bepirovirsen Achieves Functional Cure in About One in Five Hepatitis B Patients https://suwanews.sinethhospitals.com/si/news/infectious-diseases/bepirovirsen-chronic-hepatitis-b-functional-cure-phase-3 Suwa News si 2026-10-03T10:58:08+00:00 දීර්ඝකාලීන හෙපටයිටිස් B සහිත ඇතැම් රෝගීන්ට පරීක්ෂණාත්මක antisense ඖෂධයකින් “ක්‍රියාකාරී සුවයක්” ලබාගත හැකි බව 3 වන අදියර පරීක්ෂණ පෙන්වයි https://suwanews.sinethhospitals.com/news/clinical-trials/retatrutide-triumph-2-weight-loss-type-2-diabetes Suwa News en 2026-10-03T10:58:08+00:00 Retatrutide Produces 20.8% Mean Weight Loss in Phase 3 Diabetes Trial https://suwanews.sinethhospitals.com/si/news/clinical-trials/retatrutide-triumph-2-weight-loss-type-2-diabetes Suwa News si 2026-10-03T10:58:08+00:00 ත්‍රිත්ව හෝමෝන ඖෂධයක් වන Retatrutide දියවැඩියා පරීක්ෂණයකදී සාමාන්‍යයෙන් 21%කට ආසන්න බර අඩුවීමක් පෙන්වයි https://suwanews.sinethhospitals.com/news/clinical-trials/safiglipron-oral-small-molecule-glp1-outstand-1 Suwa News en 2026-10-03T10:58:08+00:00 Investigational Oral GLP-1 Pill Safiglipron Lowers HbA1c in Phase 3 Trial https://suwanews.sinethhospitals.com/si/news/clinical-trials/safiglipron-oral-small-molecule-glp1-outstand-1 Suwa News si 2026-10-03T10:58:08+00:00 ආහාර හෝ උපවාස වේලාවන්ට සීමා නොවී ලබාගත හැකි පරීක්ෂණාත්මක GLP-1 පෙත්තක් 3 වන අදියර පරීක්ෂණයකදී සාර්ථක ප්‍රතිඵල පෙන්වයි https://suwanews.sinethhospitals.com/news/cancer/vcn01-pancreatic-cancer-virage-phase-2b-trial Suwa News en 2026-10-03T10:58:08+00:00 Experimental Virus Added to Chemotherapy Shows Encouraging Results in Pancreatic Cancer Trial https://suwanews.sinethhospitals.com/si/news/cancer/vcn01-pancreatic-cancer-virage-phase-2b-trial Suwa News si 2026-10-03T10:58:08+00:00 අග්න්‍යාශ පිළිකා පරීක්ෂණයකදී Chemotherapy සමඟ එක් කළ පරීක්ෂණාත්මක වෛරස් ප්‍රතිකාරයකින් දිරිගන්වන ප්‍රතිඵල https://suwanews.sinethhospitals.com/news/new-treatments/onswik-insulin-efsitora-once-weekly-type-2-diabetes-fda Suwa News en 2026-10-03T10:58:08+00:00 FDA Approves Onswik as the Second Once-Weekly Insulin in the US https://suwanews.sinethhospitals.com/si/news/new-treatments/onswik-insulin-efsitora-once-weekly-type-2-diabetes-fda Suwa News si 2026-10-03T10:58:08+00:00 දෙවන වර්ගයේ දියවැඩියාව සහිත වැඩිහිටියන් සඳහා සතියකට එක් වරක් ලබාදෙන ඉන්සියුලින් ඖෂධයට FDA අනුමැතිය https://suwanews.sinethhospitals.com/news/brain-mental-health/tavapadon-juvmo-parkinson-disease-fda-approval Suwa News en 2026-10-03T10:58:08+00:00 FDA Approves Tavapadon, a New D1/D5-Targeted Parkinson Treatment https://suwanews.sinethhospitals.com/si/news/brain-mental-health/tavapadon-juvmo-parkinson-disease-fda-approval Suwa News si 2026-10-03T10:58:08+00:00 පාකින්සන් රෝගය සඳහා නව ආකාරයක ඩෝපමීන් ප්‍රතිකාරයක් වන Tavapadon සඳහා FDA අනුමැතිය https://suwanews.sinethhospitals.com/news/genetics-precision-medicine/tiratricol-emcitate-mct8-deficiency-fda-approval Suwa News en 2026-10-03T10:58:08+00:00 FDA Approves Tiratricol as First Treatment for MCT8 Deficiency https://suwanews.sinethhospitals.com/si/news/genetics-precision-medicine/tiratricol-emcitate-mct8-deficiency-fda-approval Suwa News si 2026-10-03T10:58:08+00:00 දුර්ලභ MCT8 තයිරොයිඩ් හෝමෝන ප්‍රවාහන ආබාධය සඳහා වන ප්‍රථම ප්‍රතිකාරයට FDA අනුමැතිය https://suwanews.sinethhospitals.com/news/new-treatments/zilurgisertib-fop-heterotopic-ossification-fda Suwa News en 2026-09-27T12:00:00+00:00 FDA Approves New Oral Treatment for Rare Disease That Causes Bone to Form in Soft Tissues https://suwanews.sinethhospitals.com/news/new-treatments/belzutifan-lenvatinib-advanced-kidney-cancer-fda Suwa News en 2026-09-27T12:00:00+00:00 FDA Approves New Drug Combination for Advanced Kidney Cancer After Immunotherapy https://suwanews.sinethhospitals.com/news/new-treatments/obinutuzumab-childhood-nephrotic-syndrome-fda Suwa News en 2026-09-27T12:00:00+00:00 FDA Approves Obinutuzumab to Prevent Relapses in Childhood-Onset Nephrotic Syndrome https://suwanews.sinethhospitals.com/news/clinical-trials/radiotherapy-after-surgery-atypical-meningioma-roam-trial Suwa News en 2026-09-27T12:00:00+00:00 Radiotherapy After Surgery Halves Recurrence Risk in Atypical Meningioma Trial https://suwanews.sinethhospitals.com/si/news/clinical-trials/radiotherapy-after-surgery-atypical-meningioma-roam-trial Suwa News si 2026-09-27T12:00:00+00:00 ශල්‍යකර්මයෙන් පසු Radiotherapy ලබා දීමෙන් Atypical Meningioma නැවත මතුවීමේ අවදානම අඩකින් අඩු වෙයි